PSA
43
3
IVZ
45
2
MDLZ
26
2
SEE
45
3
IFF
45
-2
CSCO
58
-2
TAP
40
-5
MCO
71
4
XYL
25
2
FLR
46
4
CNP
49
2
NOC
47
2
NVDA
56
5
LMT
40
13
RSG
47
2
PHM
43
3
XEL
50
-3
PYPL
60
2
CMI
52
3
WMT
66
2
PSA
43
3
IVZ
45
2
MDLZ
26
2
SEE
45
3
IFF
45
-2
CSCO
58
-2
TAP
40
-5
MCO
71
4
XYL
25
2
FLR
46
4
CNP
49
2
NOC
47
2
NVDA
56
5
LMT
40
13
RSG
47
2
PHM
43
3
XEL
50
-3
PYPL
60
2
CMI
52
3
WMT
66
2
Financhill
Back

BioLife Solutions 10K Form

Buy
53

BLFS
BioLife Solutions

Last Price:
$26.43
Seasonality Move:
30.5%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-10 10Q BLFS/BioLife Solutions Quarterly
2023-11-09 10Q BLFS/BioLife Solutions Quarterly
2023-08-09 10Q BLFS/BioLife Solutions Quarterly
2023-05-11 10Q BLFS/BioLife Solutions Quarterly
2022-11-09 10Q BLFS/BioLife Solutions Quarterly
2022-08-09 10Q BLFS/BioLife Solutions Quarterly

Receive BLFS News And Ratings

See the #1 stock for the next 7 days that we like better than BLFS

BLFS Financial Statistics

Sales & Book Value

Annual Sales: $143.3M
Cash Flow: $3.7M
Price / Cash Flow: 213.24
Annual Sales: $7.04
Price / Book: 3.77

Profitability

EPS (TTM): -1.01000
Net Income (TTM): $-46M
Gross Margin: $46.8M
Return on Equity: -13.95%
Return on Assets: -11.61%

BioLife Solutions Earnings Forecast

Key BioLife Solutions Financial Ratios

  • The Gross Profit Margin over the past 35 years for BLFS is 32.63%.
  • The Selling, General & Administrative Expenses for BLFS have been equal to 56.05% of Gross Profit Margin.
  • The Research & Development expenses have been 13.12% of Revenue.
  • The Interest Expense is -0.49% of Operating Income.
  • The Net Earning history of BLFS is -46.36% of Total Revenues.
  • Per Share Earnings over the last 35 years have been positive in 15 years.

BioLife Solutions Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: BLFS
CUSIP: 09062W
Website: biolifesolutions.com

Debt

Debt-to-Equity Ratio: 0.06
Current Ratio: 2.78
Quick Ratio: 1.62

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 77.71

BLFS Technical Analysis vs Fundamental Analysis

Buy
53
BioLife Solutions (BLFS) is a Buy

Is BioLife Solutions a Buy or a Sell?

  • BioLife Solutions stock is rated a Buy
    The current BioLife Solutions [BLFS] share price is $26.42. The Score for BLFS is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.